Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 30, 2023

Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer

JAMA Network Open

 

Additional Info

JAMA Network Open
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial
JAMA Netw Open 2023 Dec 01;6(12)e2346094, EX Chen, JM Loree, E Titmuss, DJ Jonker, HF Kennecke, S Berry, F Couture, CE Ahmad, JR Goffin, P Kavan, M Harb, B Colwell, S Samimi, B Samson, T Abbas, N Aucoin, F Aubin, S Koski, AC Wei, D Tu, CJ O'Callaghan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading